John C Roche sold $193k of THG
President and CEO at HANOVER INSURANCE GROUP, INC.. 1,100 shares at an average of $175.14, traded Mar 26, 2025, filed Mar 28, 2025.
Score components
- +25RoleCEO
- +12Trade size$193k at market
- 0Share of holdings soldSold 0.9% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -6.3%, 3m -2.5%, 6m +4.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-25-006497, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 26, 2025 | MOption exercise Common Stock10b5-1 | +900 | $77.91 | $70k | 125,178 | Mar 28, 2025 |
| Mar 26, 2025 | SOpen-market sale Common Stock10b5-1 | -900 | $175.17 | $158k | 124,278 | Mar 28, 2025 |
| Mar 27, 2025 | MOption exercise Common Stock10b5-1 | +200 | $77.91 | $16k | 124,478 | Mar 28, 2025 |
| Mar 27, 2025 | SOpen-market sale Common Stock10b5-1 | -200 | $175.01 | $35k | 124,278 | Mar 28, 2025 |
| Mar 26, 2025 | MOption exercise Common Stock Option (right to buy)derivative10b5-1 | -900 | $0.00 | $0 | 9,807 | Mar 28, 2025 |
| Mar 27, 2025 | MOption exercise Common Stock Option (right to buy)derivative10b5-1 | -200 | $0.00 | $0 | 9,607 | Mar 28, 2025 |
Related signals
Other insiders at HANOVER INSURANCE GROUP, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | HANOVER INSURANCE GROUP, INC. | Dennis Francis Kerrigan Executive Vice President | $1.9M 8,655 shares | -47% | |
| 48Moderate | HANOVER INSURANCE GROUP, INC. | Theodore H Bunting JR director | $275k 1,200 shares | -17% | |
| 46Moderate | HANOVER INSURANCE GROUP, INC. | Jane D Carlin director | $232k 1,000 shares | -31% | |
| 50Moderate | HANOVER INSURANCE GROUP, INC. | Bryan J Salvatore Executive Vice President | $3.0M 16,394 shares | -36% | |
| 47Moderate | HANOVER INSURANCE GROUP, INC. | Francisco Aristeguieta director | $195k 1,000 shares | -20% | |
| 30Weak | HANOVER INSURANCE GROUP, INC. | John C Roche President and CEO | $1.6M 8,358 shares | -6% | |
| 50Moderate | HANOVER INSURANCE GROUP, INC. | Dennis Francis Kerrigan Executive Vice President | $1.2M 6,262 shares | -34% | |
| 30Weak | HANOVER INSURANCE GROUP, INC. | John C Roche President and CEO | $1.0M 5,251 shares | -4% | |
| 57Moderate | HANOVER INSURANCE GROUP, INC. | Denise Lowsley Executive Vice President | $800k 4,175 shares | -52% | |
| 47Moderate | HANOVER INSURANCE GROUP, INC. | Denise Lowsley Executive Vice President | $200k 1,062 shares | -21% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.